Phibro Animal Health Corporation Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
UPDATE: Phibro Animal Health (PAHC) Tops Q2 EPS by 6c, Offers FY Guidance
February 3, 2020 4:40 PM EST(Updated - February 3, 2020 4:44 PM EST)
Phibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.34, $0.06 better than the analyst estimate of $0.28. Revenue for the quarter came in at $214 million versus the consensus estimate of $218.89 million.
Guidance:
Company sees FY20 EPS... More



